Medical condition
Cholesterol
Cholesterol is a medical condition tracked by NovaPharmaNews across 11 associated drugs and ongoing industry coverage. Explore approved and pipeline therapies, regulatory status, and the latest developments.
Associated drugs & therapies
- cholic acid (ORPHACOL) Alimentary tract and metabolism (A05)
- alirocumab (PRALUENT) Cardiovascular system (C10)
- bempedoic acid (NILEMDO) Cardiovascular system (C10)
- evinacumab (EVKEEZA) Cardiovascular system (C10)
- sebelipase alfa (KANUMA) Alimentary tract and metabolism (A16)
- mipomersen sodium (KYNAMRO) Cardiovascular system (C10)
- evolocumab (REPATHA) Cardiovascular system (C10)
- lomitapide (LOJUXTA) Cardiovascular system (C10)
- colesevelam (CHOLESTAGEL) Cardiovascular system (C10)
- laropiprant (TREVACLYN) Cardiovascular system (C10)
- inclisiran (LEQVIO) Cardiovascular system (C10)
Latest Cholesterol news
Eli Lilly and Verve's Gene Editor: A Breakthrough in Cholesterol Management
Eli Lilly announces promising results from Verve’s gene editing study, potentially transforming cholesterol treatment. Explore the implications for the pharmaceutical industry.
FDA Priority Review Granted to PharmaGiant's CholesterolRx for High Cholesterol
PharmaGiant's CholesterolRx has received FDA Priority Review for high cholesterol, potentially revolutionizing treatment options for millions of patients.
FDA Approves Repatha for Pediatric Heterozygous Familial Hypercholesterolemia
The FDA has granted approval for Repatha, a groundbreaking treatment for pediatric patients suffering from heterozygous familial hypercholesterolemia, enhancing cholesterol control.